ClinicalThought

Share

Program Content

Activities

  • MDM2/p53 Signaling in BTC
    Targeting the MDM2/p53 Signaling Pathway in Biliary Tract Cancers: Rationale and Current Status
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 09, 2024

    Expires: August 08, 2025

Faculty

cover img faculity

Patricia LoRusso, DO, PhD(h)

Associate Center Director, Experimental Therapeutics
Director, Early Phase Clinical Trials Program
Yale Cancer Center
Yale University
New Haven, Connecticut

Provided by

ProCE Banner

Supporters

Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc.